VEGFA and neoplasm: However the efficacy of NO donors or drugs able to upregulate eNOS in contributing to vessel normalization without counteracting the antineoplastic/antiangiogenic effect of drugs impairing the aberrant VEGF signaling at tumor level remains to be validated both at the experimental and the clinical level.